Home » Topics » Regulatory » Patents

Patents
RSS

Anti-IL-5R monoclonal antibodies and antagonists in development by Tanox

Dec. 29, 1998

Novel enzyme inhibitors from microbial source claimed by HMR as antidiabetics

Dec. 29, 1998

Guilford patents NAALADase inhibitors for glutamate abnormalities, prostate conditions

Dec. 28, 1998

Agents for epilepsy, stroke and brain, spinal cord trauma in development at Novartis

Dec. 28, 1998

Collaborative work by Janssen and Neurocrine Biosciences related to CRF antagonists

Dec. 28, 1998

New 5-HT4 and/or H3 receptor ligands designed at Synthelabo

Dec. 28, 1998

Somatostatin agonists from Takeda claimed for diabetes and its complications

Dec. 23, 1998

Patent assigned to Sumitomo describes new compounds for immune and inflammatory disorders

Dec. 23, 1998

Lilly develops novel 5-HT1A/5-HT1D antagonists for smoking cessation and CNS disorders

Dec. 23, 1998

New series of 5-ht1F agonists disclosed by Lilly

Dec. 23, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 12, 2025.
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026